TrialBlood2015
The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis.
Michael Deininger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
110 papers cite itlatest 60 shown
this paperpooled ittrialcites it